Brief: Addex Therapeutics Completes Capital Increase
Jan 12 (Reuters) - ADDEX THERAPEUTICS LTD ADXN.S :
* SAID ON MONDAY SUCCESSFULLY COMPLETES $11.5 MILLION
CAPITAL
INCREASE INCLUDING FULL EXERCISE OF UNDERWRITER’S OPTION TO
PURCHASE ADDITIONAL SECURITIES
* AGGREGATE GROSS PROCEEDS FROM OFFERING ARE $11.5 MLN
Source text for Eikon: ID:nGNE5Syz0c
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand